IP Library Granted Patent US 7,778,703
Granted Patent B2
US 7,778,703 · App. 10/205,475 · Granted Aug 17, 2010

Selective nerve fiber stimulation for treating heart conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,778,703
App. No.
10/205,475
Granted
Aug 17, 2010
Kind
B2
Abstract

Apparatus for treating a heart condition of a subject is provided, including an electrode device, which is adapted to be coupled to a vagus nerve of the subject. A control unit is adapted to drive the electrode device to apply to the vagus nerve a stimulating current, which is capable of inducing action potentials in a therapeutic direction in a first set and a second set of nerve fibers of the vagus nerve. The control unit is also adapted to drive the electrode device to apply to the vagus nerve an inhibiting current, which is capable of inhibiting the induced action potentials traveling in the therapeutic direction in the second set of nerve fibers, the nerve fibers in the second set having generally larger diameters than the nerve fibers in the first set.

Claims (35)

1. Apparatus for treating a condition of a subject, comprising:

an electrode device, configured to be coupled to a nerve of the subject;

a sensor configured to sense at least one feature of cardiac activity of the subject; and

a control unit, configured to:

drive the electrode device to apply to the nerve a stimulating current, which is configured to induce action potentials in (i) a first set of nerve fibers of the nerve, and (ii) a second set of nerve fibers of the nerve having generally larger diameters than the nerve fibers in the first set,

drive the electrode device to apply to the nerve an inhibiting current, which is configured to inhibit the induced action potentials in the second set of nerve fibers but not in the first set of fibers,

responsively to the at least one sensed feature of cardiac activity of the subject, configure at least one current selected from the group consisting of: the stimulating current, and the inhibiting current, and

regulate a heart rate of the subject by:

driving the electrode device to apply the stimulating and inhibiting currents in each of a plurality of cardiac cycles of the subject in respective series of pulses, each of which pulse series is applied after a delay from a sensed point in the cardiac cycle, and

varying a number of pulses applied per cardiac cycle and a length of a period of application of the respective series of pulses.

2. Apparatus according to claim 1 , wherein the control unit is configured to:

drive the electrode device to configure the stimulating current to induce the action potentials in an efferent therapeutic direction towards a heart of the subject, in the first and the second set of nerve fibers, and

drive the electrode device to configure the inhibiting current to inhibit the induced action potentials traveling in the efferent therapeutic direction in the second set of nerve fibers.

3. Apparatus according to claim 1 , wherein the control unit is configured to increase a number of action potentials traveling in the nerve by decreasing an amplitude of the applied inhibiting current.

4. Apparatus according to claim 1 , wherein the control unit is configured to decrease a number of action potentials traveling in the nerve by increasing an amplitude of the applied inhibiting current.

5. Apparatus according to claim 1 , wherein the condition includes a heart condition of the subject, and wherein the apparatus is configured to treat the heart condition.

6. Apparatus according to claim 5 , wherein the heart condition includes heart failure, and the apparatus is configured to treat the heart failure.

7. Apparatus according to claim 5 , wherein the heart condition includes cardiac arrhythmia, and the apparatus is configured to treat the cardiac arrhythmia.

8. Apparatus according to claim 1 , comprising an override, configured to be used by the subject so as to influence the application by the electrode device of the stimulating and inhibiting currents.

9. Apparatus according to claim 1 , comprising a pacemaker, wherein the control unit is configured to drive the pacemaker to apply pacing pulses to a heart of the subject.

10. Apparatus according to claim 1 , comprising an implantable cardioverter defibrillator (ICD), wherein the control unit is configured to drive the ICD to apply energy to a heart of the subject.

11. Apparatus according to claim 1 , wherein the sensor is configured to receive an electrical signal from the electrode device, and to sense the at least one feature of cardiac activity responsively to the electrical signal.

12. Apparatus according to claim 1 , wherein the electrode device comprises a cathode and a primary set of anodes, and wherein the control unit is configured to drive the cathode to apply the stimulating current, and to drive the primary set of anodes to apply the inhibiting current.

13. Apparatus according to claim 1 , wherein the control unit is configured to configure each of the series of pulses to include about one to 20 pulses.

14. Apparatus according to claim 1 , wherein the control unit is configured to drive the electrode device to configure at least one of the pulses to have a duration of between about one and three milliseconds.

15. Apparatus according to claim 1 , wherein the control unit is configured to drive the electrode device to apply the stimulating and inhibiting currents in each of the series of pulses over a period of between about one and about 200 milliseconds.

16. Apparatus according to claim 1 , wherein the control unit is configured to:

configure the stimulating current to induce the action potentials to travel in a therapeutic direction, and the inhibiting current to inhibit the induced action potentials traveling in the therapeutic direction, and

drive the electrode device to apply to the nerve a second inhibiting current, which is capable of inhibiting device-induced action potentials traveling in a non-therapeutic direction opposite the therapeutic direction in the first and second sets of nerve fibers.

17. Apparatus according to claim 1 , wherein the sensor comprises an electrocardiogram (ECG) monitor, wherein the at least one sensed feature of cardiac activity includes a feature of an ECG and wherein the sensor is configured to sense the feature of the ECG.

18. Apparatus according to claim 17 , wherein the at least one sensed feature of cardiac activity includes an ECG reading indicative of a presence of arrhythmia, and wherein the sensor is configured to sense the ECG reading indicative of the presence of the arrhythmia.

19. Apparatus according to claim 1 , wherein the at least one sensed feature of cardiac activity includes a heart rate of the subject, and wherein the sensor is configured to sense the heart rate.

20. Apparatus according to claim 19 , wherein the at least one sensed feature of cardiac activity includes indications of a plurality of heart rates of the subject at a respective plurality of points in time, and wherein the control unit is configured to receive the indications of the plurality of heart rates and to determine a measure of variability of heart rate responsive thereto.

21. Apparatus according to claim 1 , wherein the nerve includes a vagus nerve of the subject, and wherein the electrode device is configured to be coupled to the vagus nerve.

22. Apparatus according to claim 1 , wherein the sensor comprises a sensor of cardiac output, and wherein the control unit is configured to configure the at least one selected current and regulate the heart rate responsively to the sensed cardiac output.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0542 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2018
From: BIOCONTROL ,EDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 046574/0208 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
SECURITY AGREEMENT Recorded May 20, 2010
From: BIO CONTROL MEDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 024411/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: BIOCONTROL MEDICAL, LTD.
To: BIO CONTROL MEDICAL (B.C.M.) LTD.
Reel/Frame 020783/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2002
From: GROSS, YOSSI; AYAL, SHAI; COHEN, EHUD
To: BIOCONTROL MEDICAL LTD.
Reel/Frame 013409/0913 →